Cite
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
MLA
Fujiwara, Y., et al. “Famotidine vs. Omeprazole: A Prospective Randomized Multicentre Trial to Determine Efficacy in Non-Erosive Gastro-Oesophageal Reflux Disease.” Alimentary Pharmacology & Therapeutics, vol. 21, June 2005, pp. 10–18. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2005.02468.x.
APA
Fujiwara, Y., Higuchi, K., Nebiki, H., Chono, S., Uno, H., Kitada, K., Satoh, H., Nakagawa, K., Kobayashi, K., Tominaga, K., Watanabe, T., Oshitani, N., & Arakawa, T. (2005). Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics, 21, 10–18. https://doi.org/10.1111/j.1365-2036.2005.02468.x
Chicago
Fujiwara, Y., K. Higuchi, H. Nebiki, S. Chono, H. Uno, K. Kitada, H. Satoh, et al. 2005. “Famotidine vs. Omeprazole: A Prospective Randomized Multicentre Trial to Determine Efficacy in Non-Erosive Gastro-Oesophageal Reflux Disease.” Alimentary Pharmacology & Therapeutics 21 (June): 10–18. doi:10.1111/j.1365-2036.2005.02468.x.